-
Real-World Effectiveness of Atezolizumab-Bevacizumab, Lenvatinib and Sorafenib in the Patients With Unresectable Hepatocellular Carcinoma: A Multi-institutional Study in Taiwan
Sep 18, 2025, 18:38 PM -
An EQ-5D Multilayered Measure of Health-Related Quality of Life: Is There Relevance and Need for It?
Sep 18, 2025, 18:38 PM -
Real-World Utilization, Persistence, and Effectiveness of Biologic Therapies in Patients With Severe Asthma: A Multicenter Retrospective Cohort Study in Taiwan
Sep 18, 2025, 18:38 PM -
Prescription Trends for ADHD Medications in Japan, 2018-2023
Sep 18, 2025, 18:38 PM -
Use of RWE to Inform Survival Extrapolation in Health Economic Appraisals of Cancer Drugs in Sweden: A Review of National Health Economic Reports 2010-2024
Sep 18, 2025, 18:38 PM -
Estimating Healthcare Costs Associated With Ischemic Heart Disease and Stroke Using Several Different Statistical Models
Sep 18, 2025, 18:38 PM -
Potential Risk of Acute Pancreatitis With GLP-1 Receptor Agonists
Sep 18, 2025, 18:38 PM -
Association Between Barriers to Accessing General Practitioners and Emergency Department Visits in New Zealand
Sep 18, 2025, 18:38 PM -
Assessing Adoption and Feasibility of the Hong Kong Reference Framework for Preventive Care in Older Adults: A Cross-Sectional Survey of Primary Care Practitioners
Sep 18, 2025, 18:38 PM -
Leveraging Real World Radiation Medicine Health Data to Drive Evidence-Based Cancer Care Policies: An Insights From the IAEA SUNRISE Project
Sep 18, 2025, 18:38 PM -
Interventions Promoting the Acceptance and Uptake of Generic Medicines: A Systematic Review
Sep 18, 2025, 18:38 PM -
Pharmaceutical Approaches to Enhancing RWE Data Collected in Non-Interventional Studies
Sep 18, 2025, 18:38 PM -
Preferences and Willingness to Pay for Maintenance Inhalers Among Adults With Chronic Obstructive Pulmonary Disease in Thailand: A Discrete Choice Experiment
Sep 18, 2025, 18:38 PM -
Economic Evaluation of Selumetinib for Treating Pediatric Patients With Neurofibromatosis Type 1 Inoperable Plexiform Neurofibromas in Thailand
Sep 18, 2025, 18:38 PM -
Cost-Effectiveness of Dostarlimab Plus Chemotherapy for Primary Advanced or Recurrent Endometrial Cancer From Taiwan’s National Health Insurance Perspective
Sep 18, 2025, 18:38 PM -
Assessing Early Adoption of Pulsed Field Ablation for the Treatment of Atrial Fibrillation Using Claims and Hospital Charge Data
Sep 18, 2025, 18:38 PM -
German Early Benefit Assessments and the Impact of Medical Societies: An Analysis
Sep 9, 2025, 16:22 PM -
Advancing Real-World Evidence in Diffuse Large B-cell Lymphoma: Insights From EHR-Derived Data in the UK
Sep 9, 2025, 16:22 PM -
Lipid-Lowering Prescription Patterns After a Nonfatal Acute Coronary Syndrome: The Impact of Real-World Evidence on Clinical Practice With LATINO-ACS 2.0
Sep 9, 2025, 16:22 PM -
Health Technology Assessment Landscape for Medical Devices in Europe
Sep 9, 2025, 16:22 PM
